Autosomal Dominant Striatal Degeneration: A Patient Guide
At a Glance
Autosomal dominant striatal degeneration is an ultra-rare inherited movement disorder caused by PDE8B gene changes. It usually progresses slowly and can cause stiffness, slowed movement, and balance problems, while therapy, safety planning, genetic counseling, and monitoring support daily life.
Autosomal Dominant Striatal Degeneration (ADSD) is an ultra-rare genetic movement disorder that primarily affects the striatum, a deep-seated region of the brain responsible for coordinating smooth, purposeful movement [1]. Caused by mutations in the PDE8B gene, this condition disrupts the way brain cells process signals, which is thought to lead to a gradual loss of neurons in this critical command center [2]. Because it is so rare, many patients spend years seeking an answer, often finding that their symptoms are initially confused with more common neurological disorders. Understanding that this is a specific, distinct genetic condition is the first step toward building a management plan tailored to your needs [3].
Living with ADSD means managing a pattern of symptoms known as parkinsonism, which typically includes muscle stiffness and a significant slowing of physical movement [3]. Unlike typical Parkinson’s disease, ADSD often progresses without the classic resting tremor, and it may be accompanied by ataxia, or a lack of coordination and balance [2]. While the term “degeneration” can be frightening, the condition is characterized by its slowly progressive nature. However, reported cases have generally progressed slowly, but the range of progression and effects on lifespan are not well established [3]. The underlying course is usually slow, but complications can still be serious, so it is important to seek urgent or emergency care for choking or breathing difficulty, a significant fall or head injury, or sudden one-sided weakness or confusion [4].
The path forward focuses on proactive, multidisciplinary care that addresses the physical challenges of the condition while prioritizing safety. Because the inheritance pattern is autosomal dominant, each child of an affected person has a 50% chance of inheriting the pathogenic variant (though penetrance, age at onset, and variant-specific risk are poorly defined), making genetic counseling a vital resource for the entire family [3]. Management is centered on a team approach, utilizing physical and occupational therapy to maintain strength and home safety, alongside speech therapy to monitor for changes in swallowing or communication [5]. By focusing on regular monitoring—particularly for “red flags” like falls or swallowing difficulties—you can take an active role in managing the condition and preserving your quality of life for years to come [6].
In this guide
5 chapters
Understanding Autosomal Dominant Striatal Degeneration (ADSD)
Learn how autosomal dominant striatal degeneration (ADSD) is linked to PDE8B mutations, movement symptoms, MRI findings, diagnosis, progression, and treatment.
Symptoms and What to Expect Over Time
Learn how autosomal dominant striatal degeneration progresses, including parkinsonism, balance and swallowing changes, warning signs, and routine monitoring.
The Genetic Blueprint of ADSD
Learn how ADSD and PDE8B variants affect inheritance, presymptomatic carriers, genetic testing, MRI findings, and family planning options for your family.
Mapping the Brain: MRI and Diagnostic Clues
Learn how MRI and PDE8B genetic testing help diagnose autosomal dominant striatal degeneration, including signal changes, DTI findings, and similar disorders.
Coordinating Your Care and Management
Learn how care for autosomal dominant striatal degeneration is coordinated, including levodopa trials, therapy, swallowing checks, and safety planning.
Common questions in this guide
What is autosomal dominant striatal degeneration?
What symptoms can ADSD cause?
How is ADSD inherited, and what does it mean for my children?
How can doctors confirm that ADSD is caused by a PDE8B variant?
What therapies can help people living with ADSD?
When is ADSD an emergency?
How quickly does ADSD progress?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Since this condition is ultra-rare, can you help me find a movement disorder center that specializes in genetic parkinsonism?
- 2.How can we confirm that my mutation is in the PDE8B gene and not the more common PDE10A or Parkinson's genes?
- 3.What is the best way to assemble a team of physical, occupational, and speech therapists who understand my specific mobility needs?
- 4.What objective signs should we track during my regular check-ups to monitor the progression of my symptoms?
- 5.What specific symptoms or events should prompt me to seek emergency care versus calling your office?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (6)
- 1
The Emerging Role of Phosphodiesterases in Movement Disorders.
Erro R, Mencacci NE, Bhatia KP
Movement disorders : official journal of the Movement Disorder Society 2021; (36(10)):2225-2243 doi:10.1002/mds.28686.
PMID: 34155691 - 2
A novel mutation of PDE8B Gene in a Japanese family with autosomal-dominant striatal degeneration.
Azuma R, Ishikawa K, Hirata K, et al.
Movement disorders : official journal of the Movement Disorder Society 2015; (30(14)):1964-7 doi:10.1002/mds.26345.
PMID: 26769607 - 3
Clinical findings of autosomal-dominant striatal degeneration and PDE8B mutation screening in parkinsonism and related disorders.
Ni J, Yi X, Liu Z, et al.
Parkinsonism & related disorders 2019; (69()):94-98 doi:10.1016/j.parkreldis.2019.11.002.
PMID: 31726290 - 4
Speech and Language outcomes in Auditory Neuropathy Spectrum Disorder (ANSD) children managed with amplification.
Ramanathan D, Mahomva C, Goldberg D, et al.
American journal of otolaryngology 2023; (44(2)):103753 doi:10.1016/j.amjoto.2022.103753.
PMID: 36577168 - 5
Frequency of Hereditary and GBA1-Related Parkinsonism in Latin America: A Systematic Review and Meta-Analysis.
Saffie Awad P, Teixeira-Dos-Santos D, Santos-Lobato BL, et al.
Movement disorders : official journal of the Movement Disorder Society 2024; (39(1)):6-16 doi:10.1002/mds.29614.
PMID: 37921246 - 6
Combined use of a double-lumen tube and Fogarty catheter to prevent the endobronchial spread of infection: a case report.
Kim J, Lee H, Park H, Jeong CY
Korean journal of anesthesiology 2016; (69(6)):619-622 doi:10.4097/kjae.2016.69.6.619.
PMID: 27924204
This page is for informational purposes only and does not constitute medical advice. Your neurologist and genetic counselor can help interpret your PDE8B result and plan individualized therapy and emergency guidance.
Get notified when new evidence is published on Autosomal dominant striatal neurodegeneration.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.